Bio-Rad Labs (BIO) Tops Q3 EPS by $1.27

Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $3.71, $1.27 better than the analyst estimate of $2.44. Revenue for the quarter came in at $715.2 million versus the consensus estimate of $661.87 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• CalPrivate Bank names Andra Frazier as chief credit officer
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c